Rimadyl vet.
Active substance
ATC code
Species
Canine and feline.
Indications
| Dogs: | For the control of post-operative pain and inflammation following orthopaedic and soft tissue (including intra-ocular) surgery. |
| Cats: | For the control of post-operative pain following surgery. |
Dose to be administered and administration route
| Dogs: | The recommended dosage is 4.0 mg/kg bodyweight (1 ml/12.5kg bodyweight), by intravenous or subcutaneous injection, best given preoperatively, either at the time of premedication or induction of anaesthesia. To extend analgesic and anti-inflammatory cover postoperatively, parenteral therapy may be followed with Rimadyl tablets at 4mg/kg/day for up to 5 days. |
| Cats: | The recommended dosage is 4 mg/kg (0.24ml/3.0kg bodyweight) by subcutaneous or intravenous injection, best given pre-operatively at the time of induction of anaesthesia. Due to the longer half life in cats and narrower therapeutic index particular care should be taken not to exceed the recommended dose and the use of a 1 ml graduated syringe is recommended to measure the dose accurately. |
Clinical trial evidence in dogs and cats suggests only a single dose of carprofen is required in the first 24 hours peri-operatively; if further analgesia is required within this period, a single half dose (2 mg/kg) of carprofen may be given to dogs (but not cats) as necessary.
Adverse reactions
Typical undesirable effects associated with NSAIDs such as vomiting, soft faeces/diarrhoea, faecal occult blood, loss of appetite and lethargy have been reported. These adverse reactions are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal. If adverse reactions occur, use of the product should be stopped and the advice of a veterinarian should be sought. As with other NSAIDs there is a risk of rare renal, idiosyncratic hepatic or gastro-intestinal tract adverse events.
Rarely reactions at the injection site may be observed following subcutaneous injection.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Similar products
Showing 3 of 3 results
Rimadyl vet.
Rimadyl vet.
